ELASTAGEN

Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial. Elastin is a critical component of tissues in the human body which require the ability to stretch and recoil, such as the skin, lungs, arteries, elastic ligaments. Elastagen has developed a synthetic version of the elastin protein which is identical to that naturally present in the human body. Elastagen’s platform technology has... potential applications in a number of areas including skin rejuvenation, scar remodelling and tissue repair. Elastagen was founded following the acquisition of intellectual property rights to the elastin technology which was developed by Prof Weiss at the University of Sydney. The Company has since successfully attracted capital from a number of leading Australian and overseas life science venture capital groups. Elastagen’s operations have expanded from its Australian base to include production in Europe and clinical operations in the UK.
ELASTAGEN
Industry:
Biotechnology Clinical Trials Medical Medical Device
Founded:
2003-01-01
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.elastagen.com
Total Employee:
1+
Status:
Active
Contact:
+61 (0)2 9209 4054
Email Addresses:
[email protected]
Total Funding:
15.12 M USD
Technology used in webpage:
SPF Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Dreamscape Networks
Current Advisors List
Current Employees Featured
Founder
Investors List
Medical Devices Fund
Medical Devices Fund investment in Grant - Elastagen
Korea Investment Partners
Korea Investment Partners investment in Series B - Elastagen
Wellcome Trust
Wellcome Trust investment in Series B - Elastagen
GBS Ventures
GBS Ventures investment in Series B - Elastagen
Brandon Capital Partners
Brandon Capital Partners investment in Series B - Elastagen
Cicada Innovations
Cicada Innovations investment in Series B - Elastagen
AMOREPACIFIC Ventures
AMOREPACIFIC Ventures investment in Series B - Elastagen
Cicada Innovations
Cicada Innovations investment in Seed Round - Elastagen
Official Site Inspections
http://www.elastagen.com
- Host name: ip74001436.ipv4.syd02.ds.network
- IP address: 116.0.20.54
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney

More informations about "Elastagen"
Elastagen - Crunchbase Company Profile & Funding
Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial.See details»
Elastagen - Funding, Financials, Valuation & Investors - Crunchbase
Elastagen provides products that repair and augment skin by using elastin to maintain the skin’s elasticity and supple properties.See details»
Allergan picks up Australian biotech Elastagen in $95M deal
Feb 12, 2018 Dive Brief: Allergan plc will acquire clinical-stage biotech Elastagen Pty Ltd. for $95 million upfront, picking up the Australian company's tissue repair platform in a deal …See details»
Elastagen - Products, Competitors, Financials, Employees, …
Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial. Use the CB Insights Platform to …See details»
Elastagen - Company Profile - Tracxn
Dec 4, 2024 Elastagen is a clinical stage medical company with a pipeline of formulation products based on the human protein tropoelastin.The company was founded after the …See details»
Elastagen Company Profile 2024: Valuation, Investors ... - PitchBook
Elastagen General Information Description. Operator of a clinical-stage medical company intended to develop human protein tropoelastin-based products that facilitate skin …See details»
Allergan to acquire University of Sydney spinoff Elastagen
Feb 9, 2018 Elastagen Pty Ltd, a clinical stage company developing medical device products based on recombinant tropoelastin, today announced that it has entered into a definitive …See details»
Allergen Acquires Elastagen - Pharma's Almanac
Feb 13, 2018 The botox-maker adds an acne and stretch mark treatment to its portfolio. Allergan plc has agreed to acquire Elastagen Pty Ltd. Elastagen is a clinical stage company that …See details»
Elastagen - Crunchbase
Elastagen provides products that repair and augment skin by using elastin to maintain the skin’s elasticity and supple properties.See details»
Elastagen - Craft
Elastagen is engaged in developing a synthetic version of the elastin protein which is identical to that naturally present in the human body. Its platform technology has potential applications in a …See details»
Allergan to acquire Australian biotech company Elastagen
On 7th February 2018, Elastagen, a clinical-stage Australian company that uses recombinant tropoelastin, has entered into a definitive agreement with Allergan for an upfront payment of …See details»
Elastrin Therapeutics: Reverse Cardiovascular Disease
Elastrin Therapeutics platform technology a solution to heart disease, stroke, high blood pressure, copd and aneurysm. These diseases can be cured by our treatment; a nanoparticle that …See details»
Allergan to Acquire Elastagenu000b to Access Next Generation ...
Feb 7, 2018 Wound Filler Market Insights - Global Analysis and Forecast by 2023:- Get Free Samples@ https://bit.ly/2Xx5Aj9 The 'Global and Chinese Wound Filler Industry, 2013-2023 …See details»
Allergan Snaps Up Sydney Biotech for Upfront Payment of US $95M
Feb 7, 2018 BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals …See details»
University of Sydney spin-off Elastagen sold for $120m to Botox …
Feb 8, 2018 Allergan, the multinational that makes Botox just paid $120 million for a skin repair treatment from Sydney University's biochemistry lab.See details»
Allergan to Acquire Elastagen to Access Next Generation Injectable ...
Feb 6, 2018 • Clinical stage tropoelastin platform with potential applications in aesthetics, scar remodeling and surgical wound repair • Introduces key ‘youth protein’ tropoelastin to Allergan’s ...See details»
Sydney biotech Elastagen has just been bought for $120 million by …
Feb 14, 2018 A library of influence, inspiring and connecting people through knowledge, storytelling and creativity.See details»
Elastagen - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Elastagen provides products that repair and augment skin by using elastin to maintain the skin’s elasticity and supple properties.See details»
Elastagen (@elastagen) / X
The latest posts from @elastagenSee details»
Elastrin Therapeutics - Crunchbase Company Profile & Funding
Nanoparticle Therapy: A treatment that uses nanoparticles conjugated with antibodies to target and deliver active agents to damaged elastin in tissues, aiming to restore elasticity in blood …See details»